rs72466590

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_004006.3(DMD):​c.7183G>A​(p.Ala2395Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00174 in 1,209,410 control chromosomes in the GnomAD database, including 4 homozygotes. There are 652 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., 38 hem., cov: 23)
Exomes 𝑓: 0.0018 ( 4 hom. 614 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

1
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:12O:1

Conservation

PhyloP100: 1.94
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018843055).
BP6
Variant X-31836735-C-T is Benign according to our data. Variant chrX-31836735-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 94757.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=6, not_provided=1, Benign=4, Uncertain_significance=2}. Variant chrX-31836735-C-T is described in Lovd as [Benign]. Variant chrX-31836735-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00128 (144/112174) while in subpopulation NFE AF= 0.00218 (116/53229). AF 95% confidence interval is 0.00186. There are 0 homozygotes in gnomad4. There are 38 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 38 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DMDNM_004006.3 linkuse as main transcriptc.7183G>A p.Ala2395Thr missense_variant 49/79 ENST00000357033.9 NP_003997.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DMDENST00000357033.9 linkuse as main transcriptc.7183G>A p.Ala2395Thr missense_variant 49/791 NM_004006.3 ENSP00000354923 P4

Frequencies

GnomAD3 genomes
AF:
0.00128
AC:
144
AN:
112119
Hom.:
0
Cov.:
23
AF XY:
0.00111
AC XY:
38
AN XY:
34279
show subpopulations
Gnomad AFR
AF:
0.000194
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00171
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000370
Gnomad FIN
AF:
0.000164
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00218
Gnomad OTH
AF:
0.00132
GnomAD3 exomes
AF:
0.000867
AC:
159
AN:
183371
Hom.:
0
AF XY:
0.000825
AC XY:
56
AN XY:
67841
show subpopulations
Gnomad AFR exome
AF:
0.000228
Gnomad AMR exome
AF:
0.000583
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000188
Gnomad NFE exome
AF:
0.00164
Gnomad OTH exome
AF:
0.000663
GnomAD4 exome
AF:
0.00178
AC:
1957
AN:
1097236
Hom.:
4
Cov.:
30
AF XY:
0.00169
AC XY:
614
AN XY:
362654
show subpopulations
Gnomad4 AFR exome
AF:
0.000265
Gnomad4 AMR exome
AF:
0.000398
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000663
Gnomad4 SAS exome
AF:
0.0000924
Gnomad4 FIN exome
AF:
0.000272
Gnomad4 NFE exome
AF:
0.00219
Gnomad4 OTH exome
AF:
0.00167
GnomAD4 genome
AF:
0.00128
AC:
144
AN:
112174
Hom.:
0
Cov.:
23
AF XY:
0.00111
AC XY:
38
AN XY:
34344
show subpopulations
Gnomad4 AFR
AF:
0.000194
Gnomad4 AMR
AF:
0.00171
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000371
Gnomad4 FIN
AF:
0.000164
Gnomad4 NFE
AF:
0.00218
Gnomad4 OTH
AF:
0.00130
Alfa
AF:
0.00154
Hom.:
66
Bravo
AF:
0.00125
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00138
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00223
AC:
15
ExAC
AF:
0.000733
AC:
89

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:12Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:4
Likely benign, criteria provided, single submitterclinical testingMolecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart InstituteJun 10, 2019- -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpFeb 03, 2022- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 03, 2017- -
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMay 18, 2016Variant classified as Uncertain Significance - Favor Benign. The p.Ala2395Thr va riant in DMD has been reported in 1 child with unexplained sudden death (Campuza no 2014) and 1 mother of a proband with Duchenne Muscular Dystrophy (Taylor 2007 ). It has also been identified in 0.1% (59/47984) of European chromosomes, inclu ding 22 hemizygotes, by the Exome Aggregation Consortium (ExAC, http://exac.broa dinstitute.org; dbSNP rs72466590). Computational prediction tools and conservati on analysis suggest that the p.Ala2395Thr variant may not impact the protein, th ough this information is not predictive enough to rule out pathogenicity. In sum mary, while the clinical significance of the p.Ala2395Thr variant is uncertain, these data suggest that it is more likely to be benign. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 26, 2014- -
not provided Benign:5
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 21, 2022- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 27, 2021This variant is associated with the following publications: (PMID: 17259292, 23757202, 25447171, 19937601) -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Duchenne muscular dystrophy Benign:2
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Dilated cardiomyopathy 3B Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsOct 31, 2018This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Becker muscular dystrophy;C3668940:Dilated cardiomyopathy 3B Other:1
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
18
DANN
Benign
0.96
DEOGEN2
Benign
0.25
.;.;T;.;.
FATHMM_MKL
Benign
0.75
D
LIST_S2
Benign
0.85
T;T;.;T;T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.019
T;T;T;T;T
MetaSVM
Benign
-0.94
T
MutationTaster
Benign
1.0
D;D;D;D;D;N;N
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.88
N;.;N;.;N
REVEL
Benign
0.15
Sift
Benign
0.47
T;.;T;.;T
Sift4G
Benign
0.71
T;T;T;T;T
Polyphen
0.14
.;.;B;.;.
Vest4
0.17, 0.12, 0.22, 0.049
MVP
0.84
MPC
0.016
ClinPred
0.012
T
GERP RS
4.8
gMVP
0.17

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72466590; hg19: chrX-31854852; API